Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2014-04-07 · Food and Drug Administration, HHS · Rules and Regulations

Rules and Regulations. Notification of withdrawal of approval; correction

271 words·~1 min read·/register/2014/04/07/2014-07702

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4910-13-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Parts 556 and 558 [Docket No. FDA-2014-N-0002] Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug Applications for Combination Drug Medicated Feeds Containing an Arsenical Drug; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notification of withdrawal of approval; correction. SUMMARY: The Food and Drug Administration
(FDA)published a document in the **Federal Register** of February 27, 2014, concerning the voluntary withdrawal of approval of new animal drug applications (NADAs). The document contained an incorrect list of NADAs. DATES: This correction is effective April 7, 2014. FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9019, *George.haibel@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: In FR Doc. 2014-02616, appearing on page 10974 in the **Federal Register** of February 27, 2014, the following corrections are made: On page 10974, in the third column, in the 2d line of the “SUMMARY” section remove “69” and add in its place “68”. On page 10975, the first bulleted text “Huvepharma AD, 5th Floor, 3A Nikolay Haitov Str., 1113 Sofia, Bulgaria has requested that FDA withdraw approval of the following 16 NADAs and 8 ANADAs” is corrected to read “Huvepharma AD, 5th Floor, 3A Nikolay Haitov Str., 1113 Sofia, Bulgaria, has requested that FDA withdraw approval of the following 15 NADAs and 8 ANADAs”; and on the same page in the table, the entry “013-461 3-NITRO (roxarsone)/AMPROL Plus (amprolium and ethopabate).” is removed. Dated: April 2, 2014. Bernadette Dunham, Director, Center for Veterinary Medicine. [FR Doc. 2014-07702 Filed 4-4-14; 8:45 am]
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.